Jp. Richie et al., EFFECT OF PATIENT AGE ON EARLY DETECTION OF PROSTATE-CANCER WITH SERUM PROSTATE-SPECIFIC ANTIGEN AND DIGITAL RECTAL EXAMINATION, Urology, 42(4), 1993, pp. 365-374
This study was designed to determine the effects of age by decade on t
he efficacy of digital rectal examination (DRE) and serum prostate-spe
cific antigen (PSA) for early detection of prostate cancer in men aged
fifty and over. A prospective multicenter clinical trial was conducte
d at six university centers. All 6,630 male volunteers underwent a ser
um PSA (Hybritech, Tandem) determination and DRE. Quadrant biopsies of
the prostate were performed if PSA was > 4 ng/mL or DRE suspicious. A
total of 1,167 biopsies were performed, and 264 cancers were detected
. The cancer detection rate increased from 3 percent in men aged fifty
to fifty-nine to 14 percent in men eighty years or older (p < 0.0001)
. PSA detected significantly more of the total cancers than DRE at all
age ranges (p < 0.05). The positive predictive values (PPV) for PSA w
ere 32 percent (50-59 years), 30 percent (60-69 years), 34 percent (70
-79 years), and 38 percent (80 + years). The corresponding PPVs for DR
E were 17 percent, 21 percent, 25 percent, and 38 percent. Eighteen pe
rcent of the cancers were detected solely by DRE, whereas 45 percent o
f cancers were detected solely by PSA. Thus, the use of both tests in
combination provided the highest rate of detection in all age groups.
One hundred-sixty patients underwent radical prostatectomy and patholo
gic staging. Cancer was organ-confined in 74 percent (25/34) of men ag
ed fifty to fifty-nine, 76 percent (65/86) of men aged sixty to sixty-
nine, and 60 percent (24/40) of men aged seventy or over (chi2, < 70 v
s. greater-than-or-equal-to 70, p < 0.05). Early detection programs yi
eld a lower, yet still substantial, cancer detection rate in younger m
en, and there is a greater likelihood for detection of organ-confined
disease in this age range. Younger men have the longest projected life
expectancy and, therefore, the most to gain from early prostate cance
r detection.